Compare PBT & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBT | STAA |
|---|---|---|
| Founded | 1980 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Ophthalmic Goods |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | N/A | 1995 |
| Metric | PBT | STAA |
|---|---|---|
| Price | $31.00 | $25.57 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $28.56 |
| AVG Volume (30 Days) | 100.3K | ★ 714.7K |
| Earning Date | 03-02-2027 | 11-04-2026 |
| Dividend Yield | ★ 0.91% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.37 |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | N/A | $41.56 |
| Revenue Next Year | N/A | $8.16 |
| P/E Ratio | ★ $57.37 | $70.32 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.25 | $15.59 |
| 52 Week High | $37.00 | $35.87 |
| Indicator | PBT | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 44.97 | 54.40 |
| Support Level | $27.51 | $21.56 |
| Resistance Level | $32.25 | $26.22 |
| Average True Range (ATR) | 1.47 | 1.40 |
| MACD | 0.12 | 0.01 |
| Stochastic Oscillator | 54.01 | 33.76 |
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole, and others across Texas. The company earns the majority of its revenue in the form of royalties received through its properties.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.